Eaton Vance Management Haemonetics Corp Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Haemonetics Corp stock. As of the latest transaction made, Eaton Vance Management holds 8,004 shares of HAE stock, worth $684,742. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,004

Previous 8,007 0.04%

Holding current value

$684,742

Previous $522,000 13.6%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $189 - $235	-3 Reduced 0.04%	8,004 $593,000
Q2 2022 Aug 15, 2022	SELL	$49.27 - $66.08 $66,218 - $88,811	-1,344 Reduced 14.37%	8,007 $522,000
Q1 2022 May 16, 2022	SELL	$43.77 - $63.22 $17,726 - $25,604	-405 Reduced 4.15%	9,351 $591,000
Q4 2021 Feb 14, 2022	BUY	$49.55 - $74.59 $21,455 - $32,297	433 Added 4.64%	9,756 $435,000
Q3 2021 Nov 15, 2021	SELL	$57.6 - $70.59 $22.5 Million - $27.5 Million	-389,861 Reduced 97.66%	9,323 $609,000
Q2 2021 Aug 16, 2021	SELL	$51.81 - $118.56 $33 Million - $75.4 Million	-636,369 Reduced 61.45%	399,184 $26.6 Million
Q1 2021 May 17, 2021	BUY	$111.01 - $139.48 $8.71 Million - $10.9 Million	78,498 Added 8.2%	1,035,553 $115 Million
Q4 2020 Feb 12, 2021	SELL	$88.75 - $119.95 $10.3 Million - $13.9 Million	-115,614 Reduced 10.78%	957,055 $114 Million
Q3 2020 Nov 13, 2020	BUY	$75.65 - $93.58 $10.3 Million - $12.8 Million	136,643 Added 14.6%	1,072,669 $93.6 Million
Q2 2020 Nov 20, 2020	BUY	$84.96 - $118.91 $27,442 - $38,407	323 Added 0.03%	936,026 $83.8 Million
Q2 2020 Aug 13, 2020	BUY	$84.96 - $118.91 $30.2 Million - $42.3 Million	355,692 Added 61.33%	935,703 $83.8 Million
Q1 2020 May 14, 2020	BUY	$74.34 - $121.82 $23.6 Million - $38.7 Million	317,460 Added 120.91%	580,011 $57.8 Million
Q4 2019 Feb 11, 2020	BUY	$114.37 - $129.46 $5.25 Million - $5.95 Million	45,945 Added 21.21%	262,551 $30.2 Million
Q3 2019 Nov 14, 2019	BUY	$117.16 - $138.52 $1.49 Million - $1.76 Million	12,731 Added 6.24%	216,606 $27.3 Million
Q2 2019 Aug 16, 2019	BUY	$81.74 - $120.34 $4.4 Million - $6.48 Million	53,819 Added 35.87%	203,875 $24.5 Million
Q1 2019 May 14, 2019	BUY	$83.25 - $102.12 $12.1 Million - $14.9 Million	145,582 Added 3253.96%	150,056 $13.1 Million
Q3 2018 Nov 13, 2018	SELL	$89.96 - $114.58 $13,404 - $17,072	-149 Reduced 3.22%	4,474 $513,000
Q2 2018 Aug 10, 2018	BUY	$71.53 - $95.75 $1,072 - $1,436	15 Added 0.33%	4,623 $415,000
Q1 2018 May 07, 2018	BUY	$60.72 - $74.41 $910 - $1,116	15 Added 0.33%	4,608 $337,000
Q4 2017 Feb 12, 2018	BUY	$44.96 - $58.99 $1,303 - $1,710	29 Added 0.64%	4,593 $267,000
Q3 2017 Nov 13, 2017	BUY	$40.38 - $44.87 $184,294 - $204,786	4,564	4,564 $205,000

Others Institutions Holding HAE

# of Institutions

333

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.39B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Haemonetics Corp Transaction History